Literature DB >> 3428047

Interaction of ethanol and glipizide in humans.

S G Hartling1, O K Faber, M L Wegmann, E Wåhlin-Boll, A Melander.   

Abstract

The hypoglycemic effect of 2.5 mg glipizide and the potentiation of this effect by ethanol were studied in 10 normal-weight nondiabetic subjects. The reductions in blood glucose concentrations were similar in time of onset and extent (2 mM) whether glipizide was taken alone or in combination with ethanol. However, the return of blood glucose toward fasting level was delayed by ethanol. Beta-Cell secretory activity, evaluated from the concentrations of insulin and C-peptide, was unchanged by ethanol. The serum glipizide concentrations were reproducible within subjects, whereas there was a considerable interindividual variation. This heterogeneity in the rise in glipizide concentration was strongly correlated with blood glucose fall and insulin secretion. Thus, ethanol can prolong but does not augment the hypoglycemia induced by glipizide. The heterogeneity in glipizide concentration seems to be caused by an interindividual variation in kinetics.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3428047     DOI: 10.2337/diacare.10.6.683

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  7 in total

1.  Differential effects of sodium bicarbonate and aluminium hydroxide on the absorption and activity of glipizide.

Authors:  K T Kivistö; P J Neuvonen
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 2.  The role of sulphonylureas in the management of type 2 diabetes mellitus.

Authors:  Marc Rendell
Journal:  Drugs       Date:  2004       Impact factor: 9.546

3.  Potentiation of the hypoglycaemic response to glipizide in diabetic patients by histamine H2-receptor antagonists.

Authors:  J Feely; W C Collins; M Cullen; A H el Debani; R S MacWalter; N R Peden; I H Stevenson
Journal:  Br J Clin Pharmacol       Date:  1993-03       Impact factor: 4.335

4.  Practical strategies to normalize hyperglycemia without undue hypoglycemia in type 2 diabetes mellitus.

Authors:  Christopher T Kodl; Elizabeth R Seaquist
Journal:  Curr Diab Rep       Date:  2008-10       Impact factor: 4.810

Review 5.  Antihyperglycaemic agents. Drug interactions of clinical importance.

Authors:  A J Scheen; P J Lefèbvre
Journal:  Drug Saf       Date:  1995-01       Impact factor: 5.606

Review 6.  Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use.

Authors:  A Melander; P O Bitzén; O Faber; L Groop
Journal:  Drugs       Date:  1989-01       Impact factor: 9.546

Review 7.  Optimal management of type 2 diabetes in patients with increased risk of hypoglycemia.

Authors:  Morgan Anderson; Jason Powell; Kendall M Campbell; James R Taylor
Journal:  Diabetes Metab Syndr Obes       Date:  2014-03-06       Impact factor: 3.168

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.